MedPage Today -- More than one-fifth of dialysis patients received a contraindicated antithrombotic medication when they underwent percutaneous coronary intervention (PCI), raising their risk of adverse outcomes, a new study found.
MedPage Today -- More than one-fifth of dialysis patients received a contraindicated antithrombotic medication when they underwent percutaneous coronary intervention (PCI), raising their risk of adverse outcomes, a new study found.